Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
about
Bacterial Infections in Hematopoietic Stem Cell Transplant RecipientsNew Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesThere should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacyBacterial temporal dynamics enable optimal design of antibiotic treatmentAntimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease: A monocenter retrospective study in China.Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.Screening for Gram-negative bacteria: Impact of preanalytical parameters.Antimicrobial resistance in Asia: current epidemiology and clinical implicationsDetecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.Antibiotic resistance in cancer patients.Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.The challenge of antibiotic resistance in haematology patients.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy.Multidrug-resistant bacteria in hematology patients: emerging threats.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Prevalence and risk factors of Gram-negative bacilli causing blood stream infection in patients with malignancyEscherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality.Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies.Characteristics and outcomes of Klebsiella pneumoniae bacteraemia in Hong Kong.Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.Repeat gram-negative hospital-acquired infections and antibiotic susceptibility: A systematic review.Treatment of extended-spectrum β-lactamase-producing (ESBLs) infections: what have we learned until now?The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
P2860
Q26799576-29F0F7C1-138B-439E-8A77-342547559F02Q26799580-BC0BC597-778D-412B-B9D2-38CD23F6F646Q27005826-1156CA22-1E8D-4E08-94EB-FAB86EF349C9Q28546654-16311766-8AC3-4F07-B085-57DB564E249EQ33760545-80354B4C-AE12-4B74-B449-23B32AA1342EQ34564797-3F021ACC-B0D1-404B-ADC6-95E8CADDB458Q35738292-BAF74E89-3446-43B7-8A00-E9452C704410Q37128301-9EC3AF34-EE1A-42A5-ADEC-AD8C462B882FQ37192102-954F8734-17DE-48EC-B06C-82DE1DC488B1Q38048860-5562699E-CBE3-490F-A739-FF5531FA01FAQ38115356-00E95E3D-A819-41AC-A15D-58BD15C50A22Q38185120-FFFF05DC-557F-4147-8B25-A88A180DEAF3Q38212258-CB576ED7-B6CA-40F2-B7A0-C8051C2AEB0FQ38538705-404C4FF4-C72D-41C3-9E62-2E4D57471E35Q38613929-248B4342-5956-4C0A-B6C3-70E44F22802AQ38620812-C884038C-597C-4CC4-A6EC-CF8880CB27EDQ38665505-7BD49224-1FF0-451C-8C0F-0EDB2C1459C4Q38838498-E95DA151-4C58-4C68-B5D9-6D6E79BE8D2BQ38875315-22298F78-98D2-43A1-8C59-D5115D64072EQ39444336-207F8983-7260-4772-9002-50BD20621EA6Q40267702-DBB1B677-EDA5-4AC0-AD4D-E8E111FF41B0Q40461715-D57FF9DA-58FF-4FF0-8798-3FF31AD2A107Q40593048-0EAF01CE-B9FA-4531-8631-D7C6A315F67FQ40706134-0D19A344-B153-47C6-BE4C-2C97582B9FDCQ40812219-DF1B2A8D-7B1E-4F8E-998F-7266BFD69BE7Q41201121-5BEC8336-DF99-41E5-A57A-2DB8B3B75FEFQ41389003-5C92041C-E5BA-4E22-A0A8-42BA9EEEB937Q42242524-8E594B51-8D64-4459-8CF6-0340804BF866Q47727051-0D5AE354-87E5-4665-A6BC-F0D7A3D1B638Q58694612-CD8F0056-CE3A-4D67-8BDC-1C71B6E76644Q58770666-29DA9D1D-AE2C-41B3-B192-2FFF5AF7770B
P2860
Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Risk factors for infection and ...... s with hematologic malignancy.
@en
type
label
Risk factors for infection and ...... s with hematologic malignancy.
@en
prefLabel
Risk factors for infection and ...... s with hematologic malignancy.
@en
P2093
P2860
P1433
P1476
Risk factors for infection and ...... s with hematologic malignancy.
@en
P2093
Cheol-In Kang
Doo Ryeon Chung
Jae-Hoon Song
Korean Network for Study of Infectious Diseases
P2860
P304
P356
10.1007/S00277-011-1247-7
P577
2011-05-10T00:00:00Z